by Debra Heine
As of April 1, the United States government has compensated only three Americans who suffered injuries or death due to the COVID-19 injections, a report from the Health Resources & Services Administration (HRSA) shows.
The payments to the three individuals, who were compensated through the Countermeasures Injury Compensation Program (CICP), were listed as $2,019.55 for anaphylaxis, $1,582.65 for myocarditis, and $1,032.69 for myocarditis.
“These long-awaited payments were overdue, highly anticipated and speculated upon. What is remarkable is that less than $5,000 was paid–total,” stated Children’s Health Defense (CHD) Acting General Counsel Kim Mack Rosenberg. “This is a tragedy and highlights the severe limitations of the program.”
A total of 11,425 Americans have filed claims after suffering injuries or death from COVID-19 vaccines or other countermeasures, according to CICP data. A total of the 11,941 claims have been filed since 2010.
Of the COVID-related claims, 10,719 are “pending review or in review,” and 22 have been found “eligible for compensation and pending benefits determination.” There have been 706 decisions, with 684 claims having been denied for the following reasons:
Requested Medical Records Not Submitted: 47
Standard of Proof Not Met and/or Covered Injury Not Sustained: 117
Missed Filing Deadline: 269
Not CICP Covered Product/Not Specified: 251
According to the CICP, out of the 11,425 COVID-19 countermeasure claims, “8,133 allege injuries/deaths from COVID-19 vaccines and 3,292 allege injuries/deaths from other COVID-19 countermeasures.”
These 3,292 claims include those where it is unclear upon initial submission of the claim whether the injury/death is alleged from a vaccine or a non-vaccine COVID-19 countermeasure.
Significantly more adverse events have been reported to the Vaccine Adverse Event Reporting System (VAERS), but those vaccine deaths and injuries appear to have fallen through the cracks.
“Prior to these payouts, none of the 287,651 serious injuries or 35,048 deaths reported to VAERS as of March 31 had been compensated under the CICP,” according to CHD. Under the Public Readiness and Emergency Preparedness (PREP) Act, the CICP is the only program available for U.S. citizens injured by the COVID-19 shots.
There have been 45 times more deaths after the COVID shots in just two years than all flu vaccine-related deaths since 1990, a meta-analysis of national and international COVID-19 vaccine adverse events showed.
CICP gives individuals one year to file a claim from the date of vaccination.
A Centers for Disease Control and Prevention “Vaccine Safety Pink Book” states that compensation may be provided to eligible individuals for medical expenses and lost income, as well as death benefits to survivors of individuals who died as a direct result of injury caused by a covered countermeasure.
The [CICP] is a Federal program that provides benefits for serious injuries that occur as a result of the administration or use of a covered countermeasure. Countermeasures are vaccines, antivirals, drugs, biologics, or medical devices used to diagnose, prevent, or treat, a declared pandemic, epidemic, or security threat.
This Program was established by the Public Readiness and Emergency Preparedness Act of 2005 (PREP Act), 42 U.S.C. § 247d-6e. The PREP Act also confers broad liability protections covering the manufacture, testing, development, distribution, or use of the designated covered countermeasure.
“A payout of roughly $1,000 for myocarditis when the mortality rate increases to 50% within five years of diagnosis is absolutely insulting,” said CHD Acting President Laura Bono. “Like the National Vaccine Injury Compensation Program that compensates all other vaccine injuries, the CICP is a pathetic, government-run program that gives complete liability protection to the very industries profiting from the COVID vaccine or product. While victims linger with their injuries, paying out-of-pocket for expenses, or at worst die, the industries run to the bank.”
– – –
Debra Heine reports for American Greatness.